Since SOD1D90A mutation is mostly observed in ALS patients with prominent UMN loss, it could be possible that changes in the levels of FN1 may offer an insight into the timing and the extent of UMN loss in patients. Here, FN1 is linked to amyotrophic lateral sclerosis.